Adimmune Corp
Vivian Lee is an experienced professional in the biotechnology and pharmaceutical industries, currently serving as Vice President of New Technology and Process Development at Adimmune Corp since August 2023. Prior to this role, Vivian held several key positions at Teruisi Pharmaceutical Inc., including Senior Vice President and Vice President of Process Development and Pilot Plant Operation, where significant advancements in CMC and clinical manufacturing capabilities were achieved. Vivian also led the Manufacturing Science and Technology team at WuXi Biologics, transforming the organization to support critical late-stage programs. Earlier experiences include leadership roles at Bayer in protein recovery process development and at Genentech in manufacturing sciences and technical services. Vivian holds a Bachelor of Science in Plant Pathology from National Taiwan University and a Master of Science in Botany/Plant Biotechnology from the University of California, Riverside.
This person is not in any teams
This person is not in any offices
Adimmune Corp
ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.